10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
GILEAD SCIENCES, INC. | ||
Ticker: GILD Fiscal Year: 2014 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2014 10-K (Filed: Feb 25, 2015) | ||
(In Millions, except shares in actual) | ||
As of | As of | |
Dec 31, 2014 | Dec 31, 2013 | |
Assets [Abstract] | ||
Assets, Current [Abstract] | ||
Cash and cash equivalents | $ 10,027 | 2,113 |
Short-term marketable securities | 101 | 19 |
Accounts receivable, net of allowances of $356 at December 31, 2014 and $252 at December 31, 2013 | 4,635 | 2,182 |
Inventories | 1,386 | 1,697 |
Deferred tax assets | 508 | 331 |
Prepaid taxes | 391 | 398 |
Prepaid expenses | 194 | 166 |
Other current assets | 472 | 91 |
Total current assets | 17,714 | 6,997 |
Assets, Noncurrent [Abstract] | ||
Property, plant and equipment, net | 1,674 | 1,166 |
Long-term portion of prepaid royalties | 466 | 199 |
Long-term deferred tax assets | 236 | 190 |
Long-term marketable securities | 1,598 | 439 |
Intangible assets, net | 11,073 | 11,900 |
Goodwill | 1,172 | 1,169 |
Other long-term assets | 731 | 519 |
Total assets | 34,664 | 22,579 |
Liabilities and Stockholders' Equity [Abstract] | ||
Current liabilities [Abstract] | ||
Accounts payable | 955 | 1,256 |
Accrued government and other rebates | 2,316 | 1,018 |
Accrued compensation and employee benefits | 316 | 243 |
Income taxes payable | 105 | 11 |
Other accrued liabilities | 1,452 | 1,071 |
Deferred revenues | 134 | 111 |
Current portion of long-term debt and other obligations, net | 483 | 2,697 |
Total current liabilities | 5,761 | 6,407 |
Liabilities, Noncurrent [Abstract] | ||
Long-term Debt, net | 11,921 | 3,939 |
Long-term income taxes payable | 562 | 162 |
Long-term deferred tax liabilities | 51 | 83 |
Other long-term obligations | 535 | 179 |
Commitments and contingencies (Note 11) | ||
Temporary Equity [Abstract] | ||
Equity component of currently redeemable convertible notes (Note 10) | 15 | 64 |
Stockholders' Equity [Abstract] | ||
Preferred stock, par value $0.001 per share; 5 shares authorized; none outstanding | 0 | 0 |
Common stock, par value $0.001 per share; shares authorized of 5,600 at December 31, 2014 and December 31, 2013; shares issued and outstanding of 1,499 at December 31, 2014 and 1,534 at December 31, 2013 | 2 | 2 |
Additional paid-in capital | 2,391 | 5,386 |
Accumulated other comprehensive income (loss) | 301 | (124) |
Retained earnings | 12,732 | 6,106 |
Total Gilead stockholders equity | 15,426 | 11,370 |
Noncontrolling interest | 393 | 375 |
Total stockholders equity | 15,819 | 11,745 |
Total liabilities and stockholders equity | 34,664 | 22,579 |
External Links | |
GILEAD SCIENCES, INC. (GILD) Fiscal Year 2014 | |
Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |